Sage Therapeutics
在场
高管
查看带有其 17 名主要高管的组织结构图
Sage Therapeutics 搜索最多的简介
- Barry Greene, Director and Chief Executive Officer
- George Golumbeski, Director
- Geno Germano, Chairman of the Board
高管在Sage Therapeutics变化
- Matt Lasmanis, Chief Technology and Innovation Officer, 已经离开公司 (新闻发布的2024十月25号).
- Kimi Iguchi, Chief Financial Officer, 已经离开公司 (新闻发布的2024十月25号).
- Anne Marie Cook, Senior Vice President, General Counsel, 已经离开公司 (新闻发布的2024十月25号).
创建提醒
跟踪 Sage Therapeutics 的高管变动
药店
Sage Therapeutics 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Sage Therapeutics 的最新新闻稿
- Sage Therapeutics Announces Dr. Jeff Jonas to Retire from Board of Directors | Sage Therapeutics, Inc.
- Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference | Sage Therapeutics, Inc.
- Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease | Sage Therapeutics, Inc.
- Press Releases | Sage Therapeutics, Inc.
- Press Releases | Sage Therapeutics, Inc.
- Press Releases | Sage Therapeutics, Inc.
- Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates | Sage Therapeutics, Inc.
- Sage Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024 | Sage Therapeutics, Inc.
- Sage Therapeutics Announces Strategic Reorganization to Prioritize ZURZUVAE® Commercialization and Focus its Development Portfolio | Sage Therapeutics, Inc.
- Press Releases | Sage Therapeutics, Inc.
- View more press releases Close
通过电子邮件
